Therapeutic Advances
Copyright ©The Author(s) 2016.
World J Hepatol. Jul 28, 2016; 8(21): 874-880
Published online Jul 28, 2016. doi: 10.4254/wjh.v8.i21.874
Table 1 Expanded morphometric criteria for hepatocellular carcinoma-liver transplantation
Ref.YearDescriptionDonor typenSurvival
Yao et al[13]20011 lesion ≤ 6.5 cm, or 2-3 lesions ≤ 4.5 cm each. Total tumor diameter ≤ 8 cmCadaveric705 yr OS: 72.4%
Herrero et al[16]20011 lesion ≤ 6 cm, or 2-3 lesions ≤ 5 cm eachCadaveric475 yr OS: 79%
Roayaie et al[19]2002Any number of lesions, 5-7 cm eachCadaveric435 yr RFS: 55%
Keneteman et al[20]20041 lesion < 7.5 cm, or multiple lesions < 5 cm eachCadaveric404 yr OS: 82.9%
4 yr RFS: 76.8%
Onaca et al[18]20071 lesion ≤ 6 cm, or 2-4 lesions ≤ 5 cm eachCadaveric12065 yr RFS: 1 lesion ≤ 6 cm: 63.9%/or 2-4 lesions 3.1 cm-5 cm each: 64.6%
Soejima et al[23]2007Any number lesions ≤ 5 cm eachLiving673 yr OS: 68.6%
Jonas et al[24]2007Single lesion and diameter, or any number of lesions ≤ 6 cm each. Total tumor diameter ≤ 15 cmLiving213 yr OS: 53%
Sugawara et al[25]2007Up to 5 lesions ≤ 5 cm eachLiving783 yr RFS: 94%
Silva et al[17]20081-3 lesions ≤ 5 cm each. Total tumor diameter ≤ 10 cmCadaveric2575 yr OS: 67%
Mazzaferro et al[21]2009The sum of the size and number of tumors not exceeding 7 in the absence of microvascular invasionBoth15565 yr OS: 71.2%